GRUENDELPARTNER advises Eckert & Ziegler BEBIG on the acquisition of WOLF-Medizintechnik

Euronext-listed Eckert & Ziegler BEBIG which is active in the medical devices segment of the healthcare industry, has acquired St. Gangloff (Thuringia, Germany) based WOLF-Medizintechnik GmbH.

WOLF-Medizintechnik is a producer of X-ray therapy units for the treatment of skin surface tumours as well as joint disorders.

The core business of Eckert & Ziegler BEBIG, located in Seneffe (Belgium), is the production and distribution of brachytherapy products for the treatment of cancer. Eckert & Ziegler BEBIG employs over 130 staff members worldwide.

A team of GRUENDELPARTNER headed by Dr. Steffen Fritzsche together with in-house counsel Michael Schmolinske has provided legal support throughout the transaction process including due diligence and negotiations. The transaction team of GRUENDELPARTNER has supported the Eckert & Ziegler Group in the past with regard to capital measures and strategic transactions.

  • GRUENDELPARTNER:
    Dr. Steffen Fritzsche (Lead, Corporate, based in Berlin),
    Anja Bayer, Denis Koudous (both Commercial and based in Leipzig)
  • In-house:
    Michael Schmolinske, LL.M.

Contact us:
GRUENDELPARTNER
Mädler-Passage, Grimmaische Str. 2-4
04109 Leipzig
Tel.: +49 341 231062-0
Fax: +49 341 231062-30
Email: ed.re1529521410ntrap1529521410ledne1529521410urg@g1529521410izpie1529521410l1529521410